Greater Glasgow and Clyde Medicines

Medicines Policies

last updated 7th September 2020

Medicine Policies

NHSGGC Medicines Governance Arrangements during the COVID-19 Pandemic

In light of the COVID-19 outbreak, ADTC had cancelled its meetings between April and July 2020.  The temporary medicines governance arrangements NHSGGC had in place during that time is summarised HERE.

NHS Greater Glasgow and Clyde Area Drug and Therapeutics Committee

Policies Relating to the Management of Medicines

Policies relating to the management of medicines, and the terms of reference of ADTC and other group in the medicines advisory structure are noted in this section.  The information contained at this site is issued on the understanding that it is the best available from the resources at our disposal at the time of issue.



Expiry Date or Comments
  Structure and General
 
1.1 Medicines Advisory Structure April 2020
1.2 Managed Introduction of New Medicines and Managed Introduction of New Oncology Medicines Under review
1.3 Medicines Governance - Interim Processes during COVID-19 May 2021
  ADTC and Subcommittees  
2.1 Area Drug and Therapeutics Committee: Terms of Reference Under review
2.2 Medicines Utilisation Subcommittee: Terms of Reference Sept 2022
2.3 Prescribing Interface Subcommittee: Terms of Reference June 2020
2.4 Therapeutic Subcommittee: Terms of Reference Under review
2.4.1 Non-medical Prescribing Policy  June 2019
2.4.2 Processes related to the Therapeutics Formularies  Sept 2019
2.4.3 Therapeutics Sub-Committee Guideline/ Formulary Checklist Sept 2019
2.5 Communications Subcommittee: Terms of Reference May 2020
2.6 Antimicrobial Utilisation Subcommittee: Terms of Reference Nov 2021
2.7 Safer Use of Medicines Subcommittee: Terms of Reference Under review 
  Formulary Management  
3.1 Formulary Management Policy (in development - In the interim, please review to Formulary Appeals and Requests for Formulary Amendments and Formulary process for non-prescription medicines and medical devices) New: In development
  Prescribing Management Group (PMG) and Subgroups  
4.1 Prescribing Management Group: Terms of Reference Feb 2020
4.2 Acute Services PMG: Terms of Reference Jan 2019
4.3 Primary Care PMG: Terms of Reference March 2018 
4.4 PMG Finance Subgroup: Terms of Reference Feb 2020
4.5 PMG Mental Health: Terms of Reference Sept 2020
  Access to Medicines   
5.1 Non-Formulary Prescribing Policy  August 2023
5.2 Peer Approved Clinical System (PACS Tier Two) Policy For related info and documentation, see HERE
April 2021
5.3

Peer Approved Clinical Systems (PACS Ultra-Orphan) Policy

Please Note: The Scottish Government published guidance about a new Ultra-Orphan Pathway in April 2019.  This guidance affects the applicability of the PACS UO process for many medicines.  For further information, see the Non-Formulary page of this website (click here)

August 2023
5.4  Management of Individual Patient Treatment Requests (IPTRs)

August 2022

5.5 Individual Patient Treatment Request (IPTR) Appeal process 
August 2022
5.6 Co-payment Policy for patients recieving aspects of care privately Under review
5.7 Acute Unlicensed Medicines Policy (ULM Policy) Oct 2022
5.8 Medicines Access Scheme Policy (in the interim see 5.8.1 and also here) New: In development
5.8.1 Medicines Access Scheme Interim Arrangements during COVID-19 Aug 2021
5.9 Ultra-Oprhan Pathway New: In development
5.10 Supply of Medicines Following Specialist Review or Clinic Appointments Dec 2020
5.10.1 Supply of Medicines Following Specialist Review - Additional Guidance for Mental Health Aug 2022
  Clinical and Handling of Medicines Policies  
6.1 Safe and Secure Handling of Medicines Policy (Primary Care) Under review
6.2 Safe and Secure Handling of Medicines Policy (Acute Division) Under review
6.3 Intravenous Flush Policy (Acute Division) Under review
6.4 Intrathecal Chemotherapy Policy  Under review 
6.5 Policy for Non-Cytotoxic Intrathecal and Intraventricular Injections Under review 
6.5.1 Register of Authorised Non-Cytotoxic Intrathecal and Intracentricular Injections (Feb 2019) Under review 
6.6 Administration of Intravenous (IV) Medicines Policy (via StaffNet)  Jan 2021
6.7 Medicines Reconciliation in Hospital  Under review 
  Clinical Guidelines  
7.1 Clinical Guidelines Framework Via StaffNet 
7.2 'How To' guides for Clinical Guideline development and Clinical Guideline Title Page Via StaffNet 
7.3  Electronic Checklist for submission of Clinical Guidelines Via StaffNet
7.4  AUC Antimicrobial Guideline Approval Process  May 2021 
  Miscellaneous  
8.1 Suspected Medicines Defect Policy Aug 2020
8.1.1 Suspected Medicines Defect Reporting Form (for use by acute pharmacy staff) Aug2020 
8.2 Symptomatic Relief Policy (Adults) Under review
8.3 Drug Alerts Procedure August 2021
8.4 PPSU Medicines Shortages Guidance Via StaffNet